Jurisdiction-sensitive / not US FDA-approved as a drug

Melatonin

Endogenous indoleamine chronobiotic — ≠ Melanotan; Circadin PR ≠ all OTC melatonin pathways.

Editorial review:

What evidence says

Evidence snapshot

This drawer marks papers. It is not a plan, a dose, or a source. A paper is a bounded report. It is not a protocol. Grades name the object. They are not a safety rating.

Identity lock. Melatonin (N-acetyl-5-methoxytryptamine) is an endogenous pineal indoleamine chronobiotic. PubChem CID 896; formula C13H16N2O2 / MW 232.28; CAS 73-31-4. ≠ Melanotan (α-MSH analogue naming collision is accidental English overlap only). Pharmaceutical prolonged-release melatonin (Circadin-class) is a regulated insomnia object in some jurisdictions; dietary-supplement melatonin is a different regulatory pathway in others. This drawer marks papers. It is not use advice.

Bottom line

Sleep meta-analyses support modest effects on selected sleep outcomes for melatonin, with heterogeneity by population, formulation, and timing. Prolonged-release melatonin has labeled/specialty insomnia framing (including Circadin-class reviews and ASD pediatric prolonged-release programs). Chronobiology reviews explain mechanism without inventing unlimited wellness claims. Melatonin is not Melanotan.

Papers

Sleep meta-analyses / systematic reviews

PMID 23691095 — Ferracioli-Oda 2013

Tested: meta-analysis of melatonin for primary sleep disorders.

Does not show: that every OTC product matches trial formulations, or Melanotan identity.

PMID 33417003 — Fatemeh 2022

Tested: systematic review and meta-analysis of melatonin supplementation on sleep quality (RCT pool).

Does not show: unlimited jet-lag or shift-work proof for every regimen studied elsewhere.

PMID 36179487 — Choi 2022

Tested: systematic reviews/meta-analyses on melatonin efficacy for chronic insomnia.

Does not show: superiority to all first-line insomnia therapies in every network.

PMID 38888087 — Cruz-Sanabria 2024

Tested: systematic review and dose-response meta-analysis optimizing time/dose framing for melatonin as a sleep-promoting drug — methods paper on published trials; this drawer still provides no use schedule.

Does not show: a universal consumer protocol endorsement.

PMID 37434463 — Maruani 2023

Tested: systematic review/meta-analysis of melatonin and ramelteon for acute and long-term insomnia disorder management (ramelteon is a different MT1/MT2 receptor agonist drug).

Does not show: that melatonin equals ramelteon.

Physiology / chronobiotic reviews

PMID 29318587 — Zisapel 2018

Tested: review of melatonin in human sleep, circadian rhythms, and regulation.

Does not show: new primary RCT data by itself.

PMID 25908646 — Claustrat 2015

Tested: review of physiological effects of melatonin in humans.

Does not show: cosmetic or athletic claims.

PMID 35176989 — Cruz-Sanabria 2023

Tested: review of melatonin as a chronobiotic with sleep-promoting properties.

Does not show: approval status in every jurisdiction.

PMID 39400423 — Comai 2024

Tested: review moving beyond traditional views of melatonin, receptors, and sleep.

Does not show: a new pivotal insomnia registration trial.

Prolonged-release / labeled-adjacent pharmaceutical framing

PMID 22429105 — Lemoine 2012

Tested: review of prolonged-release melatonin (Circadin) for insomnia treatment.

Does not show: that immediate-release dietary supplements equal the prolonged-release pharmaceutical object.

PMID 29096777 — Gringras 2017

Tested: efficacy and safety RCT of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder.

Does not show: adult OTC equivalence or Melanotan-related biology.

What is not established

That all melatonin products are interchangeable with Circadin-class prolonged-release. That meta-analytic sleep benefits equal treatment of every circadian disorder. Any connection to Melanotan I/II chemistry. Unlimited anti-aging or immune claims. This drawer does not provide use advice, schedules, or sourcing.

Selected sources

23691095 33417003 36179487 38888087 37434463 29318587 25908646 35176989 39400423 22429105 29096777

What people discuss

Reported experiences

Reported topics are not established benefits.

Watch for

Risks and unknowns

Context matters. Approval of one medicine, formulation, or use does not establish approval of products sold online or other uses. This page is educational and does not provide dosing or treatment advice.

Member discussion

Compare experiences with care.

Before posting: Describe firsthand observations and uncertainty. Do not prescribe, arrange transactions, or post private health information.

◎Verified members

Join the discussion

Verified members can contribute to compound conversations.

No approved member reports yet. Thoughtful first contributions are welcome.